Last reviewed · How we verify
NCT03940677: INNOBIOPARK
Innovative Biomarkers in de Novo Parkinson's Disease
NA trial testing Brain MRI in Parkinson's Disease in 43 participants. Terminated before completion.
9 December 2021
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 43 |
| Start date | 25 April 2019 |
| Primary completion | 9 December 2021 |
| Estimated completion | 9 December 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Brain MRI — full drug profile →
- TMS-EEG
- Behavioral and cognitive battery
- Clinical evaluation and clinical scales
Conditions studied
- Parkinson's Disease — all drugs for Parkinson's Disease →
- Healthy Controls Group - Age and Sex-matched — all drugs for Healthy Controls Group - Age and Sex-matched →
Sponsor
University Hospital, Grenoble
Who can join
30 and older, any sex, with Parkinson's Disease or Healthy Controls Group - Age and Sex-matched. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims at identifying potential new and innovative biomarkers in de novo Parkinson's disease patients. New finding will help phenotyping patients since the diagnosis of the disease and potentially also in the preclinical phase.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03940677
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Brain MRI
Trials testing the same drug.
- NCT07462507 — Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 · Phase 2 · not yet recruiting
- NCT07340736 — Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Corr · NA · not yet recruiting
- NCT06865677 — Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas · Phase 2 · terminated
- NCT06461065 — Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Ea · NA · recruiting
- NCT04796714 — AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE · Phase 4 · unknown
Other recruiting trials for Parkinson's Disease
Currently open trials in the same condition.
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
- NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03940677 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 12 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03940677.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing